D

Alto Neuroscience, Inc. ANRO

NYSE
Recommendation
Dividend Power Score
Day's Range
$26.94$29.54
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Net Income -52.88% -29.88% -17.60% -2.94% -8.37%
Total Depreciation and Amortization 4.75% 9.02% 17.01% 31.67% 51.80%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 38.08% 31.11% 10.80% 14.08% 24.25%
Change in Net Operating Assets 159.04% 652.40% 186.92% -99.19% -170.16%
Cash from Operations -48.52% -23.97% -17.56% -9.16% -16.00%
Capital Expenditure -4.91% 63.78% 70.35% 98.84% 72.41%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -4.91% 63.78% 70.35% 98.84% 72.41%
Total Debt Issued -100.00% -100.00% -96.42% 1,535.04% 1,535.04%
Total Debt Repaid 100.00% 100.00% 100.00% -- --
Issuance of Common Stock 66,737.25% 54,226.75% 45,369.60% -63.20% -99.71%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -769.84% -689.17% -515.81% 74.44% 86.92%
Cash from Financing 2,527.42% 1,385.74% 1,517.04% -55.72% -94.44%
Foreign Exchange rate Adjustments 52.17% 34.62% 14.29% -172.73% -76.92%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 513.64% 311.14% 330.75% -90.42% -133.52%